Gadolinium Contrast Agent Deposition in Children

Abstract

Over the past few years, a large number of studies have evidenced increased signal intensity in the deep brain nuclei on unenhanced T1‐MRI images achieved by the application of gadolinium‐based contrast agents (GBCAs). The deposition of gadolinium in the brain, bone, and other tissues following administration of GBCAs has also been confirmed in histological studies in rodents and in necropsy studies in adults and children. Given the distinct physiological characteristics of children, this review focuses on examining the current research on gadolinium deposition in children, particularly studies utilizing novel methods and technologies. Furthermore, the article compares safety research findings of linear GBCAs and macrocyclic GBCAs in children, with the aim of offering clinicians practical guidance based on the most recent research outcomes.Level of Evidence5Technical EfficacyStage 2